CVS Health (NYSE:CVS) Upgraded at Leerink Partners

CVS Health (NYSE:CVS) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday,Briefing.com Automated Import reports. The firm presently has a $75.00 target price on the pharmacy operator’s stock, up from their previous target price of $55.00. Leerink Partners’ price target suggests a potential upside of 18.61% from the stock’s previous close.

Other analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Piper Sandler reduced their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Evercore ISI upped their price target on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Finally, StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $68.89.

CVS Health Trading Up 15.0 %

NYSE:CVS opened at $63.23 on Thursday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health has a 1 year low of $43.56 and a 1 year high of $80.75. The stock has a market capitalization of $79.57 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. The stock has a fifty day moving average price of $50.61 and a two-hundred day moving average price of $55.92.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, sell-side analysts anticipate that CVS Health will post 5.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CVS Health

Institutional investors have recently added to or reduced their stakes in the stock. AMF Tjanstepension AB grew its position in CVS Health by 124.1% during the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after acquiring an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in shares of CVS Health by 61.9% in the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock valued at $934,000 after buying an additional 5,679 shares in the last quarter. Procyon Advisors LLC bought a new position in shares of CVS Health in the third quarter valued at about $202,000. Creative Planning lifted its position in CVS Health by 23.5% during the 3rd quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock worth $15,776,000 after buying an additional 47,737 shares in the last quarter. Finally, Sumitomo Life Insurance Co. grew its holdings in CVS Health by 3.0% during the 3rd quarter. Sumitomo Life Insurance Co. now owns 17,692 shares of the pharmacy operator’s stock worth $1,112,000 after acquiring an additional 516 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.